Provectus Biopharmaceuticals Inc (PVCT)
0.1964
0.00 (0.00%)
USD |
OTCM |
Apr 25, 13:44
Provectus Biopharmaceuticals Total Return Price: 0.1964 for April 25, 2024
Total Return Price Chart
Historical Total Return Price Data
Date | Value |
---|---|
April 24, 2024 | 0.194 |
April 23, 2024 | 0.1948 |
April 22, 2024 | 0.1948 |
April 19, 2024 | 0.1948 |
April 18, 2024 | 0.195 |
April 17, 2024 | 0.19 |
April 16, 2024 | 0.1799 |
April 15, 2024 | 0.1675 |
April 12, 2024 | 0.1674 |
April 11, 2024 | 0.1819 |
April 10, 2024 | 0.1697 |
April 09, 2024 | 0.16 |
April 08, 2024 | 0.1446 |
April 05, 2024 | 0.149 |
April 04, 2024 | 0.1532 |
April 03, 2024 | 0.1599 |
April 02, 2024 | 0.1746 |
April 01, 2024 | 0.1901 |
March 28, 2024 | 0.1829 |
March 27, 2024 | 0.20 |
March 26, 2024 | 0.197 |
March 25, 2024 | 0.20 |
March 22, 2024 | 0.1906 |
March 21, 2024 | 0.198 |
March 20, 2024 | 0.1999 |
Date | Value |
---|---|
March 19, 2024 | 0.1975 |
March 18, 2024 | 0.20 |
March 15, 2024 | 0.2169 |
March 14, 2024 | 0.2024 |
March 13, 2024 | 0.2067 |
March 12, 2024 | 0.2136 |
March 11, 2024 | 0.2035 |
March 08, 2024 | 0.1988 |
March 07, 2024 | 0.2132 |
March 06, 2024 | 0.17 |
March 05, 2024 | 0.1683 |
March 04, 2024 | 0.1687 |
March 01, 2024 | 0.158 |
February 29, 2024 | 0.1487 |
February 28, 2024 | 0.1461 |
February 27, 2024 | 0.145 |
February 26, 2024 | 0.1437 |
February 23, 2024 | 0.1421 |
February 22, 2024 | 0.1449 |
February 21, 2024 | 0.142 |
February 20, 2024 | 0.1416 |
February 16, 2024 | 0.1389 |
February 15, 2024 | 0.1358 |
February 14, 2024 | 0.1364 |
February 13, 2024 | 0.1335 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
0.0315
Minimum
Mar 20 2020
0.2169
Maximum
Mar 15 2024
0.0801
Average
0.0675
Median
Nov 29 2019
Total Return Price Benchmarks
Insmed Inc | 24.91 |
NeuroMetrix Inc | 4.35 |
Intra-Cellular Therapies Inc | 72.19 |
Rhythm Pharmaceuticals Inc | 38.16 |
Amylyx Pharmaceuticals Inc | 1.775 |